lewis-x-antigen and Common-Bile-Duct-Neoplasms

lewis-x-antigen has been researched along with Common-Bile-Duct-Neoplasms* in 1 studies

Trials

1 trial(s) available for lewis-x-antigen and Common-Bile-Duct-Neoplasms

Article	Year
[Radioimmunologic analysis of trypsin and C-peptide tumor markers for evaluation of treatment efficiency in patients with pancreatic and Vater's ampulla cancer]. Klinicheskaia khirurgiia, 1993, Issue:5 A radioimmunological analysis of the changes in concentration of tumour markers CA 19-9, REA, beta 2-microglobulin, trypsin and C-peptide was carried out in 53 patients with pancreatic cancer and in 14 patients with cancer of the major duodenal papilla before and 7-10 days after the treatment. A control group was comprised of 116 volunteers. The levels of the tumour markers decreased after the combined use of remote radiotherapy and pancreaticoduodenal resection (PDR). After creation of cholecysto-enteroanastomosis and performance of radiotherapy they remained without changes. Exocrine pancreatic function after remote radiotherapy, especially in combination with PDR, was sharply suppressed. Topics: Ampulla of Vater; beta 2-Microglobulin; Biomarkers, Tumor; C-Peptide; CA-19-9 Antigen; Combined Modality Therapy; Common Bile Duct Neoplasms; Humans; Lewis X Antigen; Pancreatic Neoplasms; Prohibitins; Radioimmunoassay; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Trypsin	1993

Article

Year

[Radioimmunologic analysis of trypsin and C-peptide tumor markers for evaluation of treatment efficiency in patients with pancreatic and Vater's ampulla cancer].

Klinicheskaia khirurgiia, 1993, Issue:5

A radioimmunological analysis of the changes in concentration of tumour markers CA 19-9, REA, beta 2-microglobulin, trypsin and C-peptide was carried out in 53 patients with pancreatic cancer and in 14 patients with cancer of the major duodenal papilla before and 7-10 days after the treatment. A control group was comprised of 116 volunteers. The levels of the tumour markers decreased after the combined use of remote radiotherapy and pancreaticoduodenal resection (PDR). After creation of cholecysto-enteroanastomosis and performance of radiotherapy they remained without changes. Exocrine pancreatic function after remote radiotherapy, especially in combination with PDR, was sharply suppressed.

Topics: Ampulla of Vater; beta 2-Microglobulin; Biomarkers, Tumor; C-Peptide; CA-19-9 Antigen; Combined Modality Therapy; Common Bile Duct Neoplasms; Humans; Lewis X Antigen; Pancreatic Neoplasms; Prohibitins; Radioimmunoassay; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Trypsin

1993